Occudo Quantitative Strategies’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Occudo Quantitative Strategies’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-68,516	Closed	-$399K	–	1515
2022 Q3	$399K	Sell	68,516 -138,438	-67%	-$863K	0.03%	749
2022 Q2	$1.24M	Buy	206,954 +125,013	+153%	+$640K	0.1%	310
2022 Q1	$383K	Buy	+81,941	New	+$244K	0.03%	736
2021 Q3	–	Sell	-55,555	Closed	-$139K	–	1225
2021 Q2	$139K	Sell	55,555 -4,993	-8%	-$12K	0.02%	767
2021 Q1	$176K	Buy	60,548 +49,666	+456%	+$162K	0.04%	646
2020 Q4	$35K	Buy	+10,882	New	+$36.2K	0.01%	625

Other funds holding CTIC

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return